Skip to content

Retension Pharmaceuticals, Inc. (RTSN) Insider Trading -- Recent Executive & Director Transactions

6 insiders reported 12 Form 4 transactions for Retension Pharmaceuticals, Inc. (RTSN) over the past 18 months (most recent 2026-10-13). Recent activity: BERENDT MICHAEL J (Director) Buy 4,026 shares, BERGER FRANKLIN M (Director) Buy 12,517 shares, Olds Donald (Director) Buy 5,637 shares, Bisson Sabine (CHIEF OPERATING OFFICER) Buy 1,611 shares, Keller Eric L. (CHIEF EXECUTIVE OFFICER) Buy 20,800 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-13BERENDT MICHAEL JDirectorBuy4,026$0
2026-10-13BERGER FRANKLIN MDirectorBuy12,517$0
2026-10-13Olds DonaldDirectorBuy5,637$0
2026-10-13Bisson SabineCHIEF OPERATING OFFICERBuy1,611$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICERBuy20,800$249,600
2026-10-13Sweetnam PaulCHIEF SCIENTIFIC OFFICERBuy4,026$0
2026-10-13BERENDT MICHAEL JDirectorBuy2,640$0
2026-10-13BERGER FRANKLIN MDirectorBuy10,000$120,000
2026-10-13Bisson SabineCHIEF OPERATING OFFICERBuy2,504$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICERBuy9,662$0
2026-10-13Sweetnam PaulCHIEF SCIENTIFIC OFFICERBuy2,640$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICERBuy31,368$0

Source: SEC Form 4 filings · as of 2026-10-13